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INTRODUCTION: The role of structural brain changes and their correlations with neuropsychiatric symptoms and
disability in Alzheimer’s disease are still poorly understood.
OBJECTIVE: To establish whether structural changes in grey matter volume in patients with mild Alzheimer’s disease
are associated with neuropsychiatric symptoms and disability.
METHODS: Nineteen Alzheimer’s disease patients (9 females; total mean age = 75.2 y old ¡4.7; total mean
education level = 8.5 y ¡4.9) underwent a magnetic resonance imaging (MRI) examination and voxel-based
morphometry analysis. T1-weighted images were spatially normalized and segmented. Grey matter images were
smoothed and analyzed using a multiple regression design. The results were corrected for multiple comparisons.
The Neuropsychiatric Inventory was used to evaluate the neuropsychiatric symptoms, and the Functional Activities
Questionnaire and Disability Assessment for Dementia were used for functional evaluation.
RESULTS: A significant negative correlation was found between the bilateral middle frontal gyri, left inferior
temporal gyrus, right orbitofrontal gyrus, and Neuropsychiatric Inventory scores. A negative correlation was found
between bilateral middle temporal gyri, left hippocampus, bilateral fusiform gyri, and the Functional Activities
Questionnaire. There was a positive correlation between the right amygdala, bilateral fusiform gyri, right anterior
insula, left inferior and middle temporal gyri, right superior temporal gyrus, and Disability Assessment for Dementia
scores.
CONCLUSIONS: The results suggest that the neuropsychiatric symptoms observed in Alzheimer’s disease patients
could be mainly due to frontal structural abnormalities, whereas disability could be associated with reductions in
temporal structures.
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INTRODUCTION
The worldwide projection of Alzheimer’s disease (AD)
prevalence predicts that there will be approximately 106
million patients by 2050.1 Dementia is one of the main
causes of elderly cognitive decline and functional impair-
ment,2 leading to disastrous consequences for patients and
their relatives in regard to the quality of life, and it also
causes immense expense for the healthcare system.3 The
neuropsychiatric symptoms, another highly prevalent pro-
blem even in the predementia phase,4,5 are also correlated
with additional adverse events for patients, families, and
caregivers, such as faster cognitive decline, earlier institu-
tionalization, and higher mortality.6
Clinical evidence suggests that AD patients with
different groups of neuropsychiatric symptoms have a
heterogeneous clinical evolution.7 AD patients with beha-
vior disorders might have different pathological features
when compared with AD patients without them.8 Previous
studies have shown that neuropsychiatric symptoms and
cognitive function in AD patients might have separate
structural pathologies.9 Depression and anxiety can pre-
cede in years the development of cognitive decline in
AD.10
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More specific regional associations with a range of
behavioral symptoms have been identified using different
neuroimaging modalities. Apathy was associated with
frontal structures;11,12 delusion was correlated with frontal,
parietal, and temporal structures;13 depressive symptoms
with thalamus, lentiform nucleus, and medial temporal
cortex;14 and agitation was associated with temporal and
frontal structures.12 Even with several studies, divergence of
opinion still remains as to whether cognition and behavior
are independent and heterogeneous dimensions or whether
behavior disorders are an inevitable and nonspecific
consequence in dementias.15,16 Few studies have investi-
gated the neuropathological mechanisms of functional
decline in AD. One study correlated disability with frontal,
temporal, and occipital structures.17 In addition, few studies
have explored the correlation between anatomical changes,
neuropsychiatric symptoms, and functional losses, espe-
cially in patients in developing countries.
This study was designed to clarify whether voxel-based
morphometry structural changes in grey matter volume in
patients with mild AD are associated with neuropsychiatric
symptoms and functional impairment.
METHODS
Subjects
Nineteen patients with mild AD (9 female) were recruited
from a multidisciplinary memory clinic. Their mean age was
75.2 y (SD= 4.7, range 66–86), and their mean education
level was 8.5 y (SD=4.9, range 3–19). All patients in the
study fulfilled the National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer’s
Disease and Related Disorders Association criteria for
probable Alzheimer’s disease.
Exclusion criteria included significant symptoms of
depression (Geriatric Depression Scale . 6), Functional
Assessment Staging ,3 or .4, significant radiological
evidence of ischemic brain disease (Modified Hachinski
Ischemia Score .4), previous cerebrovascular event, Mini-
Mental State Examination score ,20, or evidence of other
degenerative or secondary dementias. Other exclusion
criteria included end-stage chronic disease or unstable
medical condition, premorbid psychiatric history, antipsy-
chotic or psychoactive medication dose adjustments in the
last 2 mo before study enrolment, initial treatment with
cholinesterase inhibitors within the 2 mo before study
enrolment, significant visual or hearing impairment, age
,60 y, and any other condition that could prevent the
patient from undergoing a magnetic resonance imaging
(MRI) examination. Highly symptomatic depressive
patients were excluded, to avoid bias in cognitive assess-
ment. Their performance on this evaluation is strongly
influenced by the level of depressive symptoms.18
Procedures
Each patient and his or her caregiver had a complete
interview with a consultant geriatrician that included
assessment of demographic and medical conditions includ-
ing tobacco use, diabetes mellitus, number of medications
used on a daily basis, body mass index, waist-to-hip ratio,
number of psychoactive medications, and period of use of
cholinesterase inhibitors. The functional status assessment
was performed using the Pfeffer Functional Activities
Questionnaire, which ranged from 0 points (completely
independent) to 30 points (completely dependent), and the
Disability Assessment for Dementia, which ranged from 0%
(completely dependent) to 100% (completely independent).
The neuropsychiatric symptoms were evaluated by the
Neuropsychiatric Inventory, which ranged from 0 points
(no behavioral problems) to 144 points (maximum of
neuropsychiatric symptoms). Each participant also under-
went a cognitive evaluation and had anMRI brain scan taken.
The Neuropsychiatric Inventory, Disability Assessment for
Dementia and Functional Activities Questionnaire values
were then correlated with grey matter volume values
extracted from the patients’ MRI brain scans.
The Ethics Committee of the Universidade Federal de Sa˜o
Paulo and Hospital Santa Marceline approved the study,
and informed consent was obtained from all participants
(and their relative or guardian or caregiver) prior to
inclusion in the study.
MRI data acquisition, analysis, and postprocessing
Examination of the brain was performed for all subjects
using a 1.5 T [Magnetom Sonata (Maestro Class); Siemens
AG, Erlangen, Germany] using an eight-channel head coil. To
minimize variation in head position, subjects were positioned
by the same investigator using the orbitomeatal line as a
landmark. Two conventional sequences were performed: (a)
Axial T2-weighted fuid-attenuated inversion recovery in a
plane parallel to the anterior commissure-posterior commis-
sure (AC—PC) line [TR (repetition time) = 8,500 ms, TE (echo
time) = 107 ms, TI (inversion time) = 2,500 ms, slice thick-
ness = 5.0 mm, slice interval = 1.5 mm, FOV (field of
view)= 240 mm, matrix size = 2566256, number of excita-
tions (NEX) = 1]; and (b) Sagittal T1-gradient echo volumetric
acquisition for multiplanar reconstruction (TR=2,000 ms,
TE=3.42 ms, flip angle = 15, FOV=256 mm, 1.0 mm slice
thickness with no gaps, totaling 160 slices per slab, matrix
size= 2566256, NEX=1).
This study used the VBM5 toolbox, which utilizes and
extends the new unified segmentation approach19 implemen-
ted in Statistical Parametric Mapping (SPM5), executed in
Matlab 7.0. The sagittal T1 DICOM files were converted to
NIFTI-1 format. The converted files were then segmented into
grey and white matter and normalized using the unified
model cited above. Voxel values were modulated by Jacobian
determinants derived from the spatial normalization, thus
allowing brain structures with decreased volumes after spatial
normalization to have their total counts decreased by an
amount proportional to the degree of volume discounted. The
final voxel resolution after normalization was 1 mm.3 The
obtained grey matter images were finally smoothed with a
Gaussian filter at full width at the maximum height equal to
8 mm and entered into statistical analysis. The sumof all voxel
values within the segmented images, in native space,
approximates intracranial volume within the corresponding
partition. Intracranial volume was computed from the sum of
grey, white, and cerebral spinal fluid volume.
Statistical analysis
Demographic, clinical, cognitive, functional, and beha-
vioral data were analyzed with SPSS 13.0 (SPSS, Chicago, IL).
Prior to conducting analyses, measurements were examined
for normality using the Shapiro-Wilk test. The association
between the Neuropsychiatric Inventory and Disability
Assessment for Dementia and Functional Activities Ques-
tionnaire scores was evaluated by Pearson’s correlation
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coefficient or Spearman’s rho, when appropriate. The level of
statistical significance was set at p,0.05.
The correlations between regional grey matter volume
and the Neuropsychiatric Inventory, Functional Activities
Questionnaire, and Disability Assessment for Dementia
scores in AD patients were evaluated using the voxel-based
morphometry multiple-regression model. Brain volume and
age were used in the model as covariates. Resulting clusters
were reported as significant at a p,0.001 level, two-tailed,
uncorrected for multiple comparisons. A small volume
correction was applied when there was a strict a priori
hypothesis that was already implicated in AD pathophy-
siology (hippocampus, entorhinal and perirhinal cortices,
temporal gyri) emerging from whole brain analyses. We
performed a small volume correction, placing a sphere with
a 5-mm radius centerd at the local maxima, which was
equivalent to a volume of 500 mm,3 with a threshold of
p,0.01, corrected for multiple comparisons using the False
Discovery Rate. Unpredicted findings were considered to be
significant only if they survived small volume correction for
multiple comparisons (p,0.05).
RESULTS
Demographic, clinical, cognitive, functional, and
behavioral data
The data description of participants is fully detailed in
Table 1.
The correlation analysis of functional and behavioral scales
showed a significant association between the Disability
Assessment for Dementia and Functional Activities
Questionnaire (r=20.862, p,0.001), Disability Assessment
for Dementia and Neuropsychiatric Inventory (r=20.475,
p,0.014), and Neuropsychiatric Inventory and Functional
Activities Questionnaire (r=0.551, p,0.04).
The behavioral assessment showed that 17 out of 19
patients (89%) had at least one symptom in the behavioral
assessment according to their caregivers. Irritability was the
most frequent abnormal behavior (63%) observed in the
Neuropsychiatric Inventory symptoms field, followed by
apathy (47%), agitation (47%), delusions (42%), and
euphoria (42%). The least frequent behavior was hallucina-
tion (10%).
Neuroimaging findings and instrumental
assessment correlations
The voxel-based morphometry multiple-regression
analysis showed that there were significant negative
correlations between the grey matter volume of the bilateral
middle frontal gyri, right orbitofrontal gyrus and left
inferior temporal gyrus and total Neuropsychiatric
Inventory scores (Figure 1).
Negative correlations were found between the bilateral
fusiform gyri, left hippocampus, bilateral middle tempo-
ral gyri, and Functional Activities Questionnaire scores
(Figure 2).
Positive correlations were seen between the right amyg-
dala, bilateral fusiform gyri, right anterior insula, right
superior temporal gyrus, left inferior temporal gyrus, left
middle temporal gyrus, and Disability Assessment for
Dementia scores (Figure 3).
A positive correlation was also observed between volume
of frontal and temporal brain structures and cognitive tests.
The detailed correlation analysis is described in Table 2.
DISCUSSION
Neuropsychiatric symptoms were very prevalent in our
sample of mild AD patients. Of these symptoms, irritability
was the most frequent abnormal behavior, followed by
apathy, agitation, delusions, and euphoria. These behavioral
problems associated with AD tend to show a trajectory of
increasing prevalence and severity over time, an attribute
they share with cognitive and functional decline.4 Our paper
confirms the high prevalence that was also seen in other
studies.5,20 This different prevalence of some Neurop-
sychiatric Inventory domains could be explained by the
exclusion of highly symptomatic depressive patients, the
different dementia stage of our sample, differences in
cultural manifestations of behavior, and sample size. A
wide variation of the Functional Activities Questionnaire
scores (1-22) was also observed. This assessment tool is
based on caregiver judgement, generally influenced by the
burden of care and cultural aspects of reported disability.21
We also observed a positive correlation between cognitive
test scores and grey matter volume of frontal and temporal
structures.
Table 1 - Description of demographic, clinical, cognitive,
functional, and behavioral data.
Variable Mean SD; range Median
Age (years) 75.2 4.7; 66–86 74
Education (years) 8.5 4.9; 3–19 8
Time of cholinesterase inhibitor use
(months)
41.9 26; 4–106 36
Mini Mental State Examination 24.21 2.78; 20-29 24
Verbal fluency for letters F, A, and S 22.15 11.22; 8-56 19
Verbal fluency for animals 10.52 2.76; 6-16 11
Clock drawing test 6.10 2.67; 2-10 6
Functional Activities Questionnaire 8.89 4.5; 1-22 10
Disability Assessment for Dementia 89.36 9.96; 60-100 92
Neuropsychiatric Inventory 20.36 19.25; 0-77 16
Figure 1 - Correlations between Neuropsychiatric Inventory
scores and reduced gray matter volume in different areas of
the brain. The results are displayed at an uncorrected lp,0.001
level and plotted onto the SPM5 canonical T1 image for the
purpose of illustration.
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The voxel-based morphometry results showed significant
negative correlations between the volume of frontal struc-
tures (middle frontal gyri and right orbitofrontal gyrus),
temporal structure volume (left inferior temporal gyrus), and
total Neuropsychiatric Inventory scores. Similar findings
were also observed in previous studies, predominantly in the
voxel-based morphometry field, molecular imaging techni-
ques, and pathological studies, confirming the role of these
structures in the genesis of neuropsychiatric symptoms.
Symptoms like disinhibition have been associated with grey
matter volume reduction in the right middle frontal gyri,22
depressive symptoms and bilateral atrophy of the medial
orbitofrontal cortex,23 eating disorders with perfusion
changes of the orbitofrontal cortex,24 agitation and aberrant
motor behavior with greater neurofibrillary tangle pathology
of the orbitofrontal cortex,25 apathy with left frontal
structures,11 delusions and apathy with decreased grey
matter volume density in the frontal lobe,12 neuropsychiatric
symptoms with grey matter volume reduction of the right
lateral middle frontal gyri and right orbitofrontal cortex,26
and neuropsychiatric symptoms with greater neurofibrillary
tangle pathology of the orbitofrontal cortex.27
Significant correlations between the grey matter volume
of temporal structures (fusiform gyri, hippocampus, amyg-
dala, insula, temporal gyri) and functional impairment
(negative correlation with the Functional Activities
Questionnaire and positive correlation with Disability
Assessment for Dementia) were also observed. Contrary to
expectations, no correlation was found between disability
and frontal structures. A possible explanation for these
findings is that the functions generally assessed are
dependent on executive functions and prospective memory
impairment, closely related to temporal structures. Studies
focusing on the neuroanatomical correlation of functional
impairment in AD are rare. Disability in AD subjects was
associated with a greater overall pathologic burden of the
medial temporal, occipital, and orbital frontal regions,17 and
decreased gray matter volume in the medial frontal and
temporal-parietal cortices.28 Another study observed an
association of decreased cerebral activity in the bilateral
parietal and temporal cortices, precuneus, and left middle
frontal gyrus and the dementia scales, including instru-
mental activities of daily living.29 Previous articles have
demonstrated cognitive or behavioral (not functional)
correlation between higher senile plaque density in the
fusiform gyri and performance on visuoperceptual tests30
and insula pathology and behavioral abnormalities.31
The selective pathological involvement of some neocor-
tical areas and ventromedial temporal lobe structures,
which is common in AD,32 was also observed in our
neuroimaging findings (middle frontal gyri, middle tem-
poral gyri, and amygdala) and correlated with neuropsy-
chiatric symptoms and the Neuropsychiatric Inventory.
Bilateral grey matter volume reduction of the fusiform gyri
and left middle temporal gyri correlated with both the
Functional Activities Questionnaire and Disability
Assessment for Dementia. The left inferior temporal gyrus
was associated with both the Neuropsychiatric Inventory
and Disability Assessment for Dementia.
Results should be interpreted as preliminary and with
caution. A few limitations of the present study warrant
mentioning. A small group of AD subjects were enrolled in
the study with the absence of a control group for the clinical
assessment. Even though the controls were submitted to an
MRI scan, the same correlational analysis on the voxel-based
morphometry could not be performed, because the
Functional Activities Questionnaire, Disability Assessment
for Dementia, and Neuropsychiatric Inventory scales were
designed for dementia patients.
Figure 2 - Correlations between Functional Activities Ques-
tionnaire scores and reduced gray matter volume in different
areas of the brain. The results are displayed at an uncorrected
p,0.001 level and plotted onto the SPM5 canonical T1 image for
the purpose of illustration. R = right; L = left.
Figure 3 - Correlations between Disability Assessment for Dem-
entia scores and reduced grey matter volume in different areas
of the brain. Results are displayed at an uncorrected p,0.001
level and plotted onto the SPM5 canonical T1 image for the
purpose of illustration. R = right; L = left.
VBM correlations between behavior and disability in AD
Vasconcelos LG et al.
CLINICS 2011;66(6):1045-1050
1048
A deeper comprehension of pathophysiological mechan-
isms of behavioral and functional aspects of AD and
their related anatomic changes may shed light on a
more effective diagnostic, prognostic, and therapeutics
approach.
CONCLUSIONS
Voxel-based morphometry results suggest that the neu-
ropsychiatric symptoms observed in these AD patients
could be mainly associated with abnormalities in frontal
structures, whereas functional impairment could be mainly
associated with volume reductions in temporal structures.
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